Komodo Health

by Komodo Health  · Based in United States → — Healthcare AI & Real-World Data Analytics for Life Sciences
Family Medicine Internal Medicine Oncology
Website Demo Contact
Claim this tool
Is this the maker? Claim the company →

Contact komodo health for pricing
Regulatory Status Disclosed

Overview

Komodo Health offers a comprehensive healthcare intelligence platform designed to leverage real-world data and advanced AI for various applications across the life sciences and healthcare industries. Their platform is built on three core layers: Healthcare Map, Marmot, and Komodo Home, working together to provide actionable insights.

The Healthcare Map serves as the foundational data layer, comprising over 1 trillion linked records and 330 million patient journeys, refreshed daily. This extensive de-identified patient-level data provides a complete U.S. healthcare data foundation, essential for robust analysis and decision-making. Physicians and researchers can rely on this comprehensive dataset for understanding patient populations, disease progression, and treatment pathways.

The Marmot intelligence layer incorporates healthcare AI that is built on over 1 million validated healthcare analyses. It ensures that every output is reproducible, auditable, and rigorously tested against benchmarks. This focus on verifiable and defensible AI insights is crucial for physicians who need to trust the data informing drug development, clinical trial design, and patient care strategies.

Finally, Komodo Home acts as the interaction layer, providing a unified environment where users can centralize their workflows. This platform allows users to ask questions, run analyses, and build custom solutions, all connected to the underlying data and AI intelligence. For physicians, this means a streamlined process for accessing and utilizing complex healthcare data to inform clinical decisions and research efforts.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Healthcare Map: 1 trillion+ linked records, 330M+ patient journeys
  • Marmot: Reproducible, auditable AI insights
  • Komodo Home: Unified workflow environment
  • Real-world data analytics
  • AI-validated insights
  • Fast and accurate answers
  • Comprehensive U.S. healthcare data
  • Customizable workflows

Use Cases

  • Drug development
  • Clinical trial design
  • Patient care strategies
  • Life sciences research
  • Financial services healthcare intelligence
  • Understanding industry trends

What Physicians Need to Know

Real-World Evidence Analysis
Komodo Health's core offering is its Healthcare Map, a comprehensive, de-identified database of over 330 million U.S. patient journeys, encompassing medical and pharmacy claims, EHRs, lab results, and demographic data. This data foundation, combined with their AI platform Marmot, enables rapid and defensible real-world evidence (RWE) generation for various use cases, including health economics and outcomes research (HEOR), disease burden analysis, and treatment pathway understanding. Komodo's RWE capabilities support retrospective observational studies and the creation of synthetic control arms in clinical trials.
Clinical Trial Matching & Optimization
Komodo Health's platform, including applications like Prism and Sentinel, helps optimize clinical trial feasibility, site selection, and patient recruitment by providing real-time visibility into patient volumes and characteristics. They leverage real-world data to identify diverse patient populations, assess the impact of inclusion/exclusion criteria on trial diversity, and create external control arms, which can accelerate timelines and reduce costs, especially for rare diseases and oncology. Patient tokenization, in partnership with Datavant, allows for secure linkage of proprietary clinical trial data with Komodo's RWD to gain a more comprehensive understanding of patient journeys before, during, and after trials.
Biomedical AI Tools
Komodo Health offers AI-powered tools like MapAI and Marmot. MapAI is an NLP-powered generative AI assistant that allows non-technical users to query complex healthcare data using natural language, transforming weeks-long analyses into instant insights. Marmot is a healthcare-native AI platform built on over a million validated healthcare analyses, providing reproducible, auditable, and benchmark-tested outputs for various healthcare analytics needs, including drug development and commercial functions. These AI tools aim to democratize healthcare data analytics and accelerate decision-making.
Genomic Data Integration
Komodo Health integrates genomic data through its MapEnhance offering and strategic partnerships. MapEnhance allows the linking of Komodo's Healthcare Map with specialty datasets, including precision molecular diagnostics and rare disease genomics data from partners like GeneDx. This integration enriches clinico-genomic datasets, providing deeper insights into patient outcomes and supporting therapeutic development, particularly in rare diseases.
Literature Mining & Publication Support
Komodo Health offers Komodo Publications Planning, a scientific publications management software that supports the identification, planning, drafting, and coordination of scientific articles and content. This tool facilitates collaboration among multiple stakeholders, including external authors, and integrates with existing IT infrastructure to streamline the publication process. Komodo's platform also supports the generation of research-grade RWE insights that contribute to published research and white papers.
Target Identification
While not explicitly detailed as 'target identification' in the traditional drug discovery sense, Komodo's platform enables a deep understanding of disease progression, treatment patterns, and patient cohorts through its comprehensive Healthcare Map and AI-driven analytics. This can indirectly support target identification by revealing unmet needs, patient segments, and disease mechanisms through real-world data analysis. Their predictive alerts can also identify undiagnosed or misdiagnosed rare disease patients, which can inform therapeutic development.
Safety Signal Detection
Komodo Health's platform can be used for safety signal detection through its ability to capture precise sequences of events in a patient's journey in real-time. Their alerting solutions, including both prescriptive and predictive machine learning approaches, can identify patterns consistent with misdiagnosis or future diagnosis, and therapy-eligible patients. This capability helps in identifying potential adverse outcomes and improving patient safety.
Collaboration Features
Komodo Health's platforms, such as Komodo Publications Planning, are designed for collaboration, allowing multiple stakeholders to work together on scientific publications. Their MapLab Enterprise environment supports multi-team organizations, fostering collaboration between technical and non-technical users. Partnerships with academic institutions and other healthcare organizations also highlight their collaborative approach to research and data sharing.
Physician Tip

Komodo Health's platform can provide physicians with real-world insights into patient journeys, treatment patterns, and disease progression, helping to inform clinical practice and identify care gaps. The AI-powered alerts can assist in earlier identification of rare disease patients or those at risk, potentially leading to more timely interventions. The ability to explore therapeutic areas using natural language queries (MapAI) can democratize access to complex healthcare data, allowing physicians to quickly get answers to clinical questions.

Komodo Health's platform is built to integrate with various data sources and partners. They offer MapEnhance for integrating specialty data like genomics, EHRs, and social determinants of health (SDOH) from partners such as GeneDx, PointClickCare, and Trio Health. Komodo Health has expanded its partnership with Databricks to deliver real-time access to its Healthcare Map through Delta Sharing, enabling seamless integration with existing data environments. They also partner with Datavant for patient tokenization to securely link proprietary clinical trial data with their RWD. Additionally, Komodo Health has collaborated with Anervea.ai to develop AI-powered applications directly on Komodo's MapLab Enterprise platform. The Healthcare Map is also available on Snowflake Marketplace for seamless access to curated datasets.

Details

Category Drug Discovery & Research, Population Health Analytics, Practice Analytics & BI
Pricing Contact komodo health for pricing
  • Komodo Health has not published pricing information for their data services
  • This is common practice for data vendors and providers
  • They suggest contacting them to obtain current pricing
  • Komodo Health's commitment to delivering exceptional value suggests they provide flexible pricing options tailored to meet specific client needs
DeploymentCloud (AWS Marketplace), Salesforce Service Cloud and Experience Cloud platforms (for Medical Information Cloud)
API Available Yes
Data ExportUnknown
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated — unknown
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Family Medicine, Internal Medicine, Oncology

Social Proof

CustomersKomodo Health has over 40 platform customers building on their technology. They track 5 Komodo Health applications with 21 verified customer records in their database. They serve nearly all top global pharma firms.
Notable
Top 20 Pharma companies

What the Web Says

Komodo Health is generally well-regarded for its comprehensive healthcare data platform, leveraging a vast patient-level dataset to provide insights for life sciences, payers, and providers. Reviewers often highlight its ability to connect disparate data points and offer a holistic view of patient journeys and market dynamics, aiding in strategic decision-making and operational efficiency. While powerful, some users note a learning curve and potential for high cost.

Overall: Positive

Strengths

  • Comprehensive and granular patient-level data insights
  • Ability to connect disparate data sources for holistic views
  • Valuable for market analysis, patient journey mapping, and commercial strategy in life sciences
  • User-friendly interface once familiarized (for some users)
  • Strong analytical capabilities for various healthcare stakeholders
  • Supports identification of unmet needs and treatment patterns

Limitations

  • Can have a steep learning curve for new users
  • Potentially high cost, especially for smaller organizations
  • Data visualization and reporting features could be more customizable for some users
  • Integration with existing systems can sometimes be complex
  • Some users desire more real-time data updates
  • Specific use cases might require significant internal data expertise to leverage fully

Based on reviews from: G2, Capterra, Reddit (various healthcare/tech subreddits), Healthcare IT News, Physician forums/blogs, Tech review sites focusing on healthcare analytics

Last updated: 2026-09-12

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Komodo Health

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Business Wire
Komodo Health and NCQA Collaborate to Accelerate the Future of Healthcare Quality Measurement
Komodo Health announced a multi-year strategic effort with the National Committee for Quality Assurance (NCQA) to modernize how healthcare quality measures are developed, validated, and continuously improved. This collaboration leverages real-world data and AI to accelerate the evaluation of HEDIS measures.
2026-08
Business Wire
Komodo Health Evolves Leadership Structure and Names Miles Ennis President
Komodo Health announced an evolution of its executive leadership structure, appointing Miles Ennis as President and co-founder Web Sun as co-Chief Executive Officer alongside co-founder and CEO Arif Nathoo, MD. This aims to accelerate the company's growth as a leading vertical AI company in healthcare and life sciences.
2026-06
Business Wire
Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
Komodo Health announced an expanded strategic partnership with Alnylam Pharmaceuticals to scale Marmotu2122, Komodo's analytics AI platform, across key enterprise functions at Alnylam. This collaboration aims to move organizations beyond AI experimentation into enterprise-wide intelligence.
2026-06
The Healthcare Technology Report
Komodo Health's Arif Nathoo Is Following the Patient
This article features Komodo Health's CEO, Arif Nathoo, and discusses the company's focus on following the patient journey through its data and AI capabilities. It highlights Komodo Health's role in leveraging technology for healthcare insights.
2026-06
Komodo Health
Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation
Komodo Health launched Marmotu2122, a healthcare-native AI engine designed to be the foundational intelligence layer for patient care, enabling transparent and verifiable healthcare analytics in minutes. This platform aims to accelerate the delivery of life-saving therapies.
2025-08
PR Newswire
Helix Partners with Komodo Health, Combining Helix's Clinico-Genomic Datasets with Komodo's Healthcare Mapu00ae for Clinical & Research Impact
Helix and Komodo Health are partnering to enrich Helix's clinico-genomic datasets within the Helix Research Network by adding insights from Komodo's Healthcare Mapu00ae. This collaboration aims to provide deeper insights into medication usage, treatment adherence, and total cost of care.
2025-01
Komodo Health
New Komodo Research Paper Highlights the Adoption of High-Efficacy Therapies in Multiple Sclerosis: Real-World Insights From Germany and the U.S.
A new study led by Komodo Health and Temedica, published in *Multiple Sclerosis and Related Disorders*, evaluated the adoption of high-efficacy therapies in multiple sclerosis in Germany and the U.S. The research revealed a significant increase in the adoption of the 'hit-hard-and-early' strategy in both countries.
2024-08
Komodo Health Blog
The Growing Role of New Data Technologies and Real-World Evidence in Supporting Health Policy Evaluations
This article discusses how Komodo Health's real-world data and analytics can support federal regulators and stakeholders in evaluating health policies, such as the FDA's Risk Evaluation and Mitigation Strategy (REMS) for clozapine. It highlights the ability to analyze neutropenia outcomes more rapidly and comprehensively.
2024-11

Videos

Product demos, reviews, and walkthroughs for Komodo Health.

View all on YouTube

Frequently Asked Questions

Komodo Health's platform, powered by its 'Healthcare Map,' aggregates and analyzes de-identified patient data to provide insights into disease progression, treatment pathways, and patient outcomes. This information can help identify unmet needs, stratify patient populations for clinical trials, and accelerate the drug discovery and development process by providing a more comprehensive understanding of real-world patient journeys.
Komodo Health utilizes a vast array of de-identified, real-world patient data, including medical claims, pharmacy claims, lab results, and electronic health records. They adhere to strict HIPAA compliance standards and employ advanced de-identification techniques to protect patient privacy while still providing valuable insights for research.
Yes, Komodo Health's platform can help physicians and researchers analyze the effectiveness of various treatment alternatives across different patient cohorts. By examining real-world outcomes, the platform can provide insights into which treatments are most effective for specific patient populations, helping to inform clinical decision-making and identify areas for further research.
Komodo Health addresses limitations by providing a more holistic and real-world view of patient journeys, going beyond the often-limited scope of traditional clinical trials. Its extensive dataset allows for the analysis of diverse patient populations and long-term outcomes, which can reveal insights missed by smaller, more controlled studies.
While Komodo Health's solutions are widely adopted by pharmaceutical companies and larger research institutions for drug discovery and development, they also offer solutions that can benefit individual physician practices. These solutions can provide insights into patient populations, treatment patterns, and referral networks, aiding in better patient management and practice optimization.
Komodo Health's platform tracks de-identified prescription and claims data, offering a comprehensive view of drug utilization patterns. This allows for analysis of patient adherence to prescribed medications, identification of factors influencing non-compliance, and insights into how drugs are being used in real-world clinical practice, which is crucial for optimizing treatment strategies and improving patient outcomes.

Related Tools

Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Free
Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.
Mendel.ai
Mendel.ai
Clinical Decision Support & Reference
Mendel.ai uses Neuro-Symbolic AI to sort patient cohorts from EHRs for clinical trial matching, accelerating research.
Contact for pricing
Haystack Enroll
Haystack Health
Drug Discovery & Research
Haystack Health is a clinical trial platform that utilizes AI and care navigation to connect health plan members and ACO patients with relevant clinical trials, aiming to expand treatment access and improve outcomes.
Custom quote
Dyania Health Clinical Trial Recruitment
Dyania Health
Drug Discovery & Research
Dyania Health's AI-powered software automates patient identification from EHRs for clinical trial recruitment, serving hospitals, health systems, and pharmaceutical companies.

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-06-11 | First Added: 2026-06-11

Investors who backed Komodo Health

Funded through the company that built this tool.

Tiger Global Management
VC T1
New York, United States
$25M+
Tiger Global Management is a New York-based investment firm that operates one of the largest crossover platforms in the world, combining a…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
Felicis Ventures
VC T3
Menlo Park, United States
$1M-$5M
Felicis Ventures is a multi-stage Bay Area venture firm with a long track record of high-profile early-stage bets across consumer, enterprise, and…
AI/ML in Healthcare Biotech
AI Tool Finder
AI-powered search. Results may not be comprehensive.